Penicillin G (injectable only)

Penicillin G is a beta-lactam antibiotic that has been used in veterinary medicine for decades to treat serious bacterial infections. In guinea pigs, this medication carries significant risks and must only be administered via injection, never orally. The injectable form of Penicillin G bypasses the gastrointestinal tract, which is critical for guinea pig safety since oral penicillin and related antibiotics cause fatal disruption of the delicate cecal flora. When administered correctly by injection, Penicillin G can be an effective treatment option for severe bacterial infections in guinea pigs, though it remains a medication that exotic veterinarians typically reserve for cases where safer alternatives have failed or are unavailable.

Penicillin G works by interfering with bacterial cell wall synthesis, ultimately causing bacterial cell death. The drug binds to specific proteins called penicillin-binding proteins located inside the bacterial cell wall, preventing the cross-linking of peptidoglycan chains that give the cell wall its structural integrity. Without a functional cell wall, bacteria cannot survive and reproduce. This mechanism makes Penicillin G effective against many gram-positive bacteria and some gram-negative organisms, though susceptibility testing is recommended before use in guinea pigs to ensure the targeted bacteria will respond to treatment.

Penicillin G for guinea pigs is available only as an injectable formulation, typically administered subcutaneously or intramuscularly by a veterinarian or trained veterinary staff. The medication comes in various concentrations and formulations, including procaine penicillin G and benzathine penicillin G, which have different durations of action and injection frequencies. Procaine penicillin provides shorter-acting coverage requiring more frequent injections, while benzathine penicillin offers extended-release properties allowing for less frequent administration. The choice of formulation depends on the type and severity of infection being treated, and this decision must be made by an exotic veterinarian experienced with guinea pig medicine.

The safety profile of injectable Penicillin G in guinea pigs requires careful consideration and monitoring throughout treatment. While injectable administration avoids the fatal gastrointestinal complications associated with oral penicillin, there remains some risk of disrupting gut flora even with parenteral administration. Guinea pigs receiving Penicillin G injections must be monitored closely for any signs of decreased appetite, reduced fecal output, or changes in behavior that could indicate developing gastrointestinal problems. This medication should only be used under the direct supervision of a veterinarian experienced in exotic animal medicine, and owners should never attempt to administer penicillin to their guinea pigs without professional guidance. The importance of using only the injectable form cannot be overstated, as oral penicillin administration is considered absolutely contraindicated in guinea pigs.

The primary indication for injectable Penicillin G in guinea pigs is the treatment of severe bacterial infections when safer antibiotic alternatives have proven ineffective or are unavailable. Guinea pigs are susceptible to various bacterial infections that can become life-threatening without appropriate antibiotic therapy, and in some cases, Penicillin G may be the most effective option available. However, due to the risks associated with this medication class in cavies, exotic veterinarians typically exhaust safer options before turning to injectable penicillin. Common situations where Penicillin G injection might be considered include deep-seated abscesses, severe respiratory infections caused by susceptible organisms, and systemic bacterial infections that have not responded to first-line antibiotics.

Deep tissue abscesses represent one of the more common scenarios where injectable Penicillin G might be employed in guinea pig medicine. Guinea pigs are prone to developing abscesses, particularly around the jaw and face due to dental disease, and these infections can become chronic and difficult to resolve. When culture and sensitivity testing indicates that the causative bacteria are susceptible to penicillin and resistant to safer alternatives, injectable Penicillin G may be prescribed as part of a comprehensive treatment plan that typically includes surgical drainage and long-term antibiotic therapy. The extended-release formulations of Penicillin G can be particularly useful for managing chronic abscesses that require prolonged antibiotic coverage.

Severe respiratory infections represent another situation where Penicillin G injection might be considered, though this is relatively uncommon. Guinea pigs are susceptible to bacterial pneumonia, often caused by Bordetella bronchiseptica or Streptococcus pneumoniae, which can progress rapidly and become life-threatening. In cases where culture results indicate penicillin sensitivity and the infection has not responded to safer antibiotics such as trimethoprim-sulfamethoxazole or chloramphenicol, injectable Penicillin G may be employed as a rescue therapy. The decision to use Penicillin G for respiratory infections must weigh the risks of the medication against the severity of the infection and the availability of alternatives.

Systemic bacterial infections, including septicemia, may occasionally warrant the use of injectable Penicillin G when the causative organism demonstrates susceptibility. Guinea pigs can develop systemic infections following wounds, surgical procedures, or as complications of localized infections that have spread. In these critical situations, the broad-spectrum coverage provided by Penicillin G against many gram-positive bacteria can be valuable, particularly when combined with other antibiotics to extend coverage against gram-negative organisms. Treatment of systemic infections requires aggressive therapy and close monitoring, often including hospitalization and supportive care.

The selection of injectable Penicillin G over alternative antibiotics depends on multiple factors including culture and sensitivity results, the severity and location of infection, previous treatment failures, and individual patient factors. Exotic veterinarians familiar with guinea pig medicine understand that this medication carries inherent risks in this species and will carefully weigh these considerations before prescribing. When Penicillin G is selected, it is typically because the specific clinical situation demands its use and safer alternatives are not viable options. Cost and availability may also factor into treatment decisions, as some specialized guinea pig-safe antibiotics can be expensive or difficult to obtain.

The dosing protocol for injectable Penicillin G in guinea pigs must be determined exclusively by an exotic veterinarian experienced with cavy medicine, as improper dosing can result in treatment failure or adverse effects. Unlike many other species, guinea pigs have unique physiological characteristics that affect how drugs are processed in their bodies, making species-specific dosing essential. The veterinarian will calculate the appropriate dose based on the guinea pig's accurate body weight, which should be measured in grams using a digital gram scale, as even small errors in weight estimation can lead to significant dosing inaccuracies in these small patients. Individual patient factors such as the severity of infection, kidney and liver function, and overall health status will also influence dosing decisions.

Typical dosing guidelines for injectable Penicillin G in guinea pigs generally fall within established ranges used in exotic animal practice, though exact doses vary based on the specific formulation used and the condition being treated. Procaine penicillin G is often administered at intervals ranging from once to twice daily due to its shorter duration of action, while benzathine penicillin G may be given less frequently due to its extended-release properties. The veterinarian may choose to use combination products that contain both procaine and benzathine penicillin to provide both immediate and sustained antibiotic coverage. Maximum dose limits are carefully observed to minimize the risk of adverse effects while achieving therapeutic drug levels at the site of infection.

Treatment duration with injectable Penicillin G varies considerably depending on the type and severity of infection being treated. Acute bacterial infections may require treatment for one to two weeks, while chronic conditions such as deep-seated abscesses often necessitate extended therapy lasting several weeks to months. The veterinarian will establish an initial treatment plan and adjust duration based on clinical response, with regular recheck examinations to assess healing progress. For chronic abscesses, Penicillin G therapy is typically combined with surgical intervention and may continue until the abscess has fully resolved and surrounding tissue has healed completely.

Administration of injectable Penicillin G is performed subcutaneously or intramuscularly, with subcutaneous injection generally preferred in guinea pigs due to their small muscle mass and the potential for injection site reactions. The veterinarian or trained veterinary technician will administer injections during initial treatments and may teach experienced owners to give injections at home for extended treatment courses, though this requires proper training and demonstration. Injection sites should be rotated to prevent tissue irritation and ensure consistent drug absorption. Guinea pigs should be handled gently during injections to minimize stress, which can negatively impact their overall health and recovery. Maintaining gut motility is essential during treatment, and owners should ensure their guinea pig continues eating hay and vegetables throughout the treatment period.

If a scheduled injection is missed, owners should contact their veterinarian for guidance rather than attempting to compensate by doubling the next dose. The appropriate action when a dose is missed depends on how much time has passed and the specific dosing schedule being followed. Generally, if a missed dose is remembered within a few hours, it may be given late, but if significant time has passed, it is often better to skip the missed dose and resume the regular schedule. Doubling doses of Penicillin G is never recommended as this increases the risk of adverse effects without providing additional therapeutic benefit and could potentially overwhelm the guinea pig's ability to process the medication safely.

Completing the full course of Penicillin G treatment as prescribed is critically important for achieving successful outcomes and preventing the development of antibiotic-resistant bacteria. Stopping treatment early because the guinea pig appears to be improving can allow surviving bacteria to regrow and potentially develop resistance, making subsequent treatment more difficult. Guinea pig owners should maintain contact with their veterinarian throughout the treatment period and report any concerns about their pet's condition or ability to continue treatment. Probiotic supplementation with guinea pig-appropriate formulations may be recommended during and after antibiotic therapy to support gastrointestinal health, though this should be discussed with the prescribing veterinarian to ensure proper timing and product selection.

The general tolerability of injectable Penicillin G in guinea pigs is acceptable when the medication is administered properly and patients are monitored closely, though this antibiotic class carries inherent risks in this species that owners must understand. Most guinea pigs receiving appropriately dosed injectable Penicillin G will complete their treatment course without serious adverse effects, but vigilant monitoring is essential throughout therapy. Owners should be educated about potential side effects before treatment begins so they can recognize problems early and seek veterinary attention promptly. The exotic veterinarian will typically schedule regular recheck appointments to assess treatment response and monitor for any developing complications.

Common and relatively mild side effects of injectable Penicillin G in guinea pigs may include temporary changes in appetite or reduced interest in food immediately following injections. Some guinea pigs experience mild gastrointestinal effects even with injectable administration, as the medication can still affect gut flora to some degree after being absorbed into the bloodstream. Owners may notice softer than normal fecal pellets or slight changes in fecal output during treatment. These mild effects are usually self-limiting and resolve without intervention, but any persistent changes in appetite or fecal production should be reported to the veterinarian. Injection site reactions including temporary swelling, firmness, or discomfort at injection sites may occur, particularly with repeated injections.

Moderate side effects requiring veterinary attention include more pronounced appetite suppression, significant reduction in fecal output, or behavioral changes such as increased lethargy or hiding behavior. These signs could indicate developing gastrointestinal dysbiosis, which is the primary concern when using any penicillin-class antibiotic in guinea pigs. The veterinarian may recommend additional supportive care such as assisted feeding with critical care formula, subcutaneous fluid therapy, or gastrointestinal motility support. Changes in liver or kidney function are possible with Penicillin G therapy, particularly in guinea pigs with pre-existing organ compromise, and the veterinarian may recommend blood work monitoring during extended treatment courses.

Serious side effects of injectable Penicillin G in guinea pigs require immediate veterinary attention and may include complete anorexia, absence of fecal pellets, abdominal distension, or signs of pain such as teeth grinding or a hunched posture. These symptoms could indicate gastrointestinal stasis or developing enterotoxemia, which is the life-threatening condition that occurs when beneficial gut bacteria are destroyed and pathogenic bacteria such as Clostridium species overgrow. Allergic reactions to Penicillin G, while relatively uncommon, can occur and may manifest as facial swelling, difficulty breathing, or collapse. Any signs of allergic reaction constitute a medical emergency requiring immediate veterinary care. Neurological symptoms such as seizures are rare but possible with very high doses or in patients with impaired kidney function.

Rare side effects and long-term use concerns with injectable Penicillin G include the potential for superinfection with resistant bacteria or yeast organisms during prolonged therapy. Guinea pigs on extended Penicillin G treatment should be monitored for signs of secondary infections that might develop as normal protective flora are suppressed. Owners should be alert for any new or worsening symptoms during treatment and report these promptly. The decision to continue, modify, or discontinue Penicillin G therapy should always be made by the prescribing veterinarian based on clinical assessment. Owners should never abruptly stop antibiotic treatment without veterinary guidance, as this could lead to infection recurrence or other complications.

Known allergy or hypersensitivity to penicillin or other beta-lactam antibiotics constitutes an absolute contraindication to Penicillin G use in guinea pigs. If a guinea pig has previously experienced an allergic reaction to any penicillin-type antibiotic, alternative medications must be selected to avoid potentially life-threatening anaphylaxis. Cross-reactivity exists among different penicillin formulations and may extend to other beta-lactam antibiotics including some cephalosporins, so this history must be communicated clearly to any veterinarian treating the guinea pig. Previous adverse reactions to injectable Penicillin G, even if not clearly allergic in nature, should also be disclosed and carefully considered before prescribing this medication again.

Guinea pigs with known liver disease or significant kidney impairment may not be appropriate candidates for Penicillin G therapy, as these organs are responsible for metabolizing and eliminating the drug from the body. Impaired organ function can lead to drug accumulation and increased risk of toxicity, including neurological effects at elevated blood levels. The veterinarian may recommend blood work to assess liver and kidney function before initiating Penicillin G therapy, particularly in older guinea pigs or those with chronic health conditions. If Penicillin G must be used in patients with mild organ impairment, dose adjustments and more intensive monitoring may be required. Alternative antibiotics that do not rely heavily on renal excretion may be preferred in guinea pigs with compromised kidney function.

Pregnancy and nursing represent important considerations when deciding whether to use Penicillin G in guinea pigs, as these life stages affect both the sow and her offspring. Pregnant guinea pigs have altered drug metabolism, and some antibiotics can cross the placenta to affect developing pups. Nursing sows pass medications through their milk to suckling young, potentially affecting the fragile gastrointestinal systems of neonatal guinea pigs. While Penicillin G has been used in pregnant animals of other species, the decision to treat a pregnant or nursing guinea pig requires careful consideration of risks and benefits. The veterinarian will weigh the severity of the infection against potential risks to the pregnancy or nursing young before recommending treatment.

Oral administration of Penicillin G is absolutely and completely contraindicated in guinea pigs under any circumstances. This critical point cannot be overemphasized: oral penicillin, ampicillin, amoxicillin, and related antibiotics cause fatal disruption of guinea pig gastrointestinal flora, resulting in overgrowth of Clostridium difficile and other pathogenic bacteria that produce deadly toxins. This condition, known as antibiotic-associated enterotoxemia, is almost universally fatal and develops rapidly. The only safe route for penicillin administration in guinea pigs is by injection, and even this carries some risk. Other absolutely contraindicated oral antibiotics in guinea pigs include erythromycin, lincomycin, clindamycin, streptomycin, vancomycin, and most oral cephalosporins. Owners must understand that medications safe for humans, dogs, cats, or even rabbits may be deadly for guinea pigs, and they should never administer any antibiotic to their guinea pig without explicit veterinary direction.

Informing the veterinarian about all medications, supplements, and treatments the guinea pig is currently receiving is essential before starting Penicillin G therapy. Drug interactions can alter the effectiveness of Penicillin G, increase the risk of adverse effects, or affect the action of other medications the guinea pig may need. This includes prescription medications, over-the-counter products, herbal supplements, and even dietary supplements such as vitamin C, which is essential for guinea pig health. The veterinarian will review all current treatments and adjust the therapeutic plan as needed to minimize interaction risks while ensuring effective treatment of the bacterial infection.

Penicillin G can interact with several important drug classes used in guinea pig medicine. Concurrent use of bacteriostatic antibiotics such as tetracyclines or chloramphenicol may theoretically reduce the effectiveness of Penicillin G, as penicillins work best against actively dividing bacteria while bacteriostatic drugs inhibit bacterial growth. However, in clinical practice, combination antibiotic therapy is sometimes necessary and can be managed with appropriate timing and monitoring. Non-steroidal anti-inflammatory drugs commonly used in guinea pigs for pain management may affect kidney function and alter penicillin excretion. The veterinarian will consider these potential interactions when designing the treatment protocol and may adjust dosing schedules or choose alternative medications to minimize risks.

Vitamin C supplementation is a critical consideration for guinea pigs receiving any medication, as these animals cannot synthesize their own vitamin C and require daily dietary intake to prevent deficiency. While no direct interaction between Penicillin G and vitamin C has been established, maintaining adequate vitamin C levels is important for immune function and wound healing during infection recovery. Some guinea pig owners increase vitamin C supplementation during illness, but this should be discussed with the veterinarian to ensure appropriate dosing. Timing of vitamin C administration relative to Penicillin G injections is generally not critical since the antibiotic is given parenterally, but maintaining consistent daily vitamin C intake throughout treatment supports overall health and recovery.

Monitoring for drug interactions during Penicillin G treatment involves watching for signs that medications may be affecting each other or that the guinea pig is experiencing enhanced adverse effects. Changes in how the guinea pig responds to treatment, unexpected symptoms, or alterations in the effectiveness of other medications should be reported to the veterinarian promptly. Blood work monitoring may be recommended during extended combination therapy to assess organ function and ensure safe drug metabolism. Throughout treatment, maintaining the guinea pig's normal diet of hay, fresh vegetables, and appropriate pellets supports gastrointestinal health and provides the nutrition needed for recovery. Any changes to diet or feeding patterns should be communicated to the veterinarian, as nutrition plays an important role in medication effectiveness and overall treatment success.

General precautions for Penicillin G use in guinea pigs begin with the fundamental understanding that this medication carries significant risks in this species and should only be used when clearly indicated and under close veterinary supervision. Before treatment begins, the veterinarian should confirm the diagnosis through appropriate testing, including bacterial culture and sensitivity when possible, to ensure that Penicillin G is likely to be effective against the specific organism causing infection. Accurate body weight measurement in grams is essential for proper dosing, and owners should have access to a gram scale for ongoing weight monitoring throughout treatment. Following the veterinarian's instructions precisely regarding dose, frequency, and duration of treatment is critical for both safety and effectiveness.

While breed-specific variations in Penicillin G sensitivity have not been extensively documented in guinea pigs, certain physical characteristics may influence treatment considerations. Skinny guinea pigs, which lack normal fur covering, may be more prone to injection site reactions and may require special attention to injection technique and site rotation. Long-haired breeds such as Peruvians and Silkies do not pose specific concerns for injectable medication administration, though keeping the coat clean around injection sites helps prevent secondary irritation or infection. All guinea pigs, regardless of breed, share the fundamental sensitivity to oral penicillin-class antibiotics, and this absolute contraindication applies universally across all guinea pig varieties.

Environmental precautions during Penicillin G treatment include safe handling and storage of the medication, proper disposal of needles and syringes, and awareness of household contamination risks. Penicillin G injections should be prepared and administered in a clean area, and used sharps must be disposed of in appropriate puncture-resistant containers. In households with multiple guinea pigs, the treated individual may need temporary separation to allow monitoring of food intake and fecal production without confusion from cage mates. Handlers with known penicillin allergies should take precautions to avoid direct contact with the medication, and anyone administering injections should wash hands thoroughly before and after the procedure.

Monitoring requirements during Penicillin G treatment are extensive and should be taken seriously by guinea pig owners. Daily weight monitoring using a gram scale helps detect early appetite changes that might not be visually apparent. Tracking food and water intake, including hay consumption and vegetable consumption, provides important information about the guinea pig's condition. Fecal pellet production should be assessed at least twice daily, noting quantity, size, shape, and consistency of droppings. Any decrease in fecal output is concerning in guinea pigs and should prompt immediate veterinary consultation. Signs of treatment effectiveness, such as improvement in the original infection symptoms, should also be monitored and reported at recheck appointments.

Special population considerations for Penicillin G include senior guinea pigs over three years of age, who may have reduced organ function affecting drug metabolism and elimination. Young guinea pigs have immature organ systems and may process medications differently than adults. Immunocompromised guinea pigs, including those with concurrent illnesses or receiving immunosuppressive treatments, require especially careful monitoring during antibiotic therapy. Pregnant and nursing sows represent a special population where the risks and benefits of Penicillin G must be carefully weighed, considering potential effects on developing or nursing young. In all special populations, the prescribing veterinarian will adjust monitoring frequency and may modify dosing based on individual patient needs.

Proper storage of injectable Penicillin G is essential for maintaining medication effectiveness and safety throughout the treatment course. Most Penicillin G formulations should be stored according to manufacturer guidelines, which typically specify refrigeration between 2-8 degrees Celsius or controlled room temperature depending on the specific product. The medication should be protected from light exposure, which can degrade the active ingredient, and kept away from excessive moisture. Storage location should be secure and away from the guinea pig's habitat to prevent accidental contamination or ingestion. Checking the manufacturer's storage instructions for the specific Penicillin G product prescribed is important, as different formulations may have different requirements.

Formulation-specific storage requirements vary between different Penicillin G preparations used in veterinary medicine. Procaine penicillin G products typically require refrigeration after opening, while some benzathine formulations may be stable at room temperature. Liquid preparations should be inspected before each use for changes in color, clarity, or the presence of particles that might indicate degradation or contamination. If the medication was compounded specifically for the guinea pig patient, storage instructions from the compounding pharmacy must be followed carefully, as compounded preparations may have shorter stability periods than commercial products. Expiration dates should be noted and respected, and any remaining medication after the treatment course should be disposed of properly rather than saved for potential future use.

Safe handling of Penicillin G protects both the guinea pig and household members during the treatment period. Injection supplies including syringes, needles, and the medication vial should be kept in a designated area away from children and other pets. Needles must never be recapped by hand due to needlestick injury risk, and all sharps should be placed immediately into appropriate disposal containers after use. People with known penicillin allergies should avoid handling the medication directly, and alternative arrangements for injection administration should be made. Proper disposal of unused medication can be accomplished through veterinary clinic take-back programs, community drug disposal events, or following FDA guidelines for home medication disposal. Syringes used for medication administration should be cleaned between uses if reusing is recommended by the veterinarian, or disposed of in sharps containers if single-use supplies are provided.

Injectable Penicillin G is generally tolerated similarly across guinea pig breeds when administered properly and monitored appropriately, as the fundamental sensitivity to penicillin-class antibiotics relates to guinea pig physiology rather than breed-specific characteristics. All guinea pig breeds share the same cecal fermentation digestive system that makes oral penicillin administration deadly, and all require the same precautions when injectable penicillin is used. However, certain breed characteristics may influence practical aspects of treatment administration and monitoring, making breed awareness useful for optimizing care during antibiotic therapy.

Skinny guinea pigs, the hairless variety, present some unique considerations for injectable medication administration. The lack of fur makes injection sites more visible, which can be helpful for monitoring reactions but also means that any injection site swelling or irritation is more apparent. Hairless guinea pigs may be more susceptible to temperature fluctuations and should be kept in appropriately warm environments during treatment, as illness already stresses thermoregulation. Their exposed skin may be more sensitive to injection technique, and special care should be taken to use appropriate needle gauges and injection methods. Long-haired breeds including Peruvians, Silkies, and Texels do not pose specific concerns for injectable Penicillin G administration, though keeping fur trimmed around injection sites can facilitate administration and monitoring.

Size considerations are important for Penicillin G dosing regardless of breed, as guinea pigs vary considerably in body weight from small individuals under 700 grams to large adults exceeding 1200 grams. Accurate dosing requires precise weight measurement in grams, and smaller guinea pigs require proportionally careful attention to injection volumes to ensure accurate delivery of calculated doses. Very small doses may require dilution for accurate measurement, which should be performed by veterinary staff using sterile technique. Large guinea pigs may require higher total doses but should not exceed recommended per-kilogram maximums. Injection site rotation becomes especially important in smaller guinea pigs where limited tissue availability may concentrate repeated injections in similar areas.

Age considerations affect Penicillin G therapy decisions and monitoring in guinea pigs of all breeds. Young guinea pigs under four months of age have developing organ systems that may process medications differently than mature adults, and their smaller size requires careful dose calculation. Senior guinea pigs over three years of age may have declining kidney and liver function that affects drug elimination, potentially increasing the risk of adverse effects. Older guinea pigs are also more likely to have concurrent health conditions that complicate antibiotic therapy decisions. The veterinarian will consider age alongside other factors when determining whether Penicillin G is appropriate and how to adjust dosing and monitoring for optimal safety.

Alternative antibiotics in the same beta-lactam class are generally not recommended for guinea pigs due to shared risks, but other antibiotic classes offer safer options for treating bacterial infections in this species. Trimethoprim-sulfamethoxazole is often considered a first-line antibiotic for guinea pigs with various bacterial infections due to its relative safety and broad spectrum of activity. Chloramphenicol is another antibiotic commonly used in guinea pig medicine that does not carry the same gastrointestinal risks as penicillins. Enrofloxacin, a fluoroquinolone antibiotic, is frequently prescribed for respiratory and other infections in guinea pigs, though it should be used cautiously in young, growing animals due to potential effects on cartilage development. These alternatives should be considered before resorting to injectable Penicillin G when appropriate for the specific infection being treated.

When Penicillin G is not appropriate or has failed to resolve infection, different antibiotic classes may be employed based on culture and sensitivity results and the nature of the infection. Metronidazole is used for anaerobic bacterial infections and some protozoal conditions in guinea pigs. Azithromycin, a macrolide antibiotic, is sometimes used in guinea pig medicine though careful monitoring is required. The choice between these alternatives depends on the specific bacteria involved, the site of infection, and individual patient factors. Combination antibiotic therapy may be necessary for complex or resistant infections, and the exotic veterinarian will design appropriate treatment protocols based on clinical findings.

Complementary therapies and supportive care play important roles in guinea pig infection treatment alongside antibiotic therapy. Critical Care formula feeding supports nutrition in guinea pigs with reduced appetite during illness. Probiotic supplementation with guinea pig-appropriate products may help maintain healthy gut flora during and after antibiotic treatment, though this should be discussed with the veterinarian to ensure appropriate timing and product selection. Vitamin C supplementation at appropriate doses supports immune function during infection recovery. Subcutaneous fluid therapy may be needed for dehydrated patients, and pain management with guinea pig-safe medications supports comfort and appetite during recovery. Owners should never substitute or modify antibiotic therapy without explicit veterinary guidance, as inappropriate changes could lead to treatment failure or development of resistant infections.